Caberlin 0.5 mg
Caberlin 0.5 mg Tab Salt Information :
What is Caberlin 0.5 mg?
Caberlin 0.5 mg (Cabergoline) Tablet is used for Hyperprolactinemic disorders, Moderate to severe labor pain, Moderate to severe surgery pain and other conditions. Caberlin 0.25 mg Tablet may also be used for purposes not listed in this medication guide.Caberlin 0.25 mg Tablet contains Cabergoline as an active ingredient.Caberlin 0.25 mg Tablet works by inhibiting the effect on pituitary prolactin cells. Sun Pharma manufactures Caberlin 0.25 mg Tablet.Detailed information related to Caberlin 0.25 mg Tablet's uses, composition, dosage, side effects and reviews is listed below.
Uses of Caberlin 0.5mg Tab :
Cabergoline Can Help Treat Symptoms Associated With Irregular Menstruation, Unwanted Breast Milk Production, Infertility, Bone Loss, And Sexual Problems. People With Pituitary Gland Tumors Also Produce Too Much Prolactin. Cabergoline Is Often Used To Help Treat This Condition.
Side Effects of Caberlin 0.5mg Tab :
Decrease In BP, Dizziness, Vertigo, Headache, Nausea, Sleeplessness, Abdominal Pain, Dyspepsia, Gastritis, Weakness, Fatigue, Constipation, Vomiting, Breast Pain, Hot Flushes, Depression, Tingling, Leg Cramps, Raynaud's Syndrome, Psychosis With Hallucinations, Delusions And Confusion. Potentially Fatal: Risk Of Serotinin Syndrome With Sibutramine; Avoid Combination.
Drug Interactions of Caberlin 0.5mg Tab :
Increased Risk Of Orthostatic Hypotension When Used With Antihypertensives. May Increase Vasoconstriction Effect Of Dopamine. May Reduce Vasodilation Effect Of Nitroglycerin. Concurrent Use With SSRIs Or TCAs May Increase The Risk Of Serotonin Syndrome. Potentially Fatal: Risk Of Serotonin Syndrome With Sibutramine.
Contraindications of Caberlin 0.5mg Tab :
Hypersensitivity To Ergot Derivatives. Uncontrolled Hypertension.
Mechanism of Action of Caberlin 0.5mg Tab :
Cabergoline Is A Long-Acting Dopamine D2-Agonist. It Inhibits Prolactin Secretion Through Hypothalamic Inhibitory Control Exerted Through The Release Of Dopamine. Absorption: Absorbed From The GI Tract. Undergoes 1st Pass Effect. Distribution: Plasma Protein Binding: About 40%. Metabolism: Extensively Metabolised To Inactive Metabolites. Excretion: Mainly Via Faeces.
Special Precautions for Caberlin 0.5mg Tab :
CV Disease, Raynaud's Syndrome, Renal Or Hepatic Impairment, Peptic Ulcer, GI Bleeding, History Of Psychosis, Hypertension. May Affect Ability To Drive Or Operate Machinery. Pregnancy, Lactation. Prolonged Use And/Or Usage Of High Doses May Lead To Psychiatric Disorders, Pleural/Retroperitoneal Fibrosis Or Cardiac Valvular Fibrosis. Monitor Serum Prolactin Level Mthly Until Normalisation. Monitor Hepatic Function Regularly In Patients With Hepatic Impairment.